Comprehensive antibody profiling of mRNA vaccination in children
Y. C. Bartsch, K. J. St Denis, P. Kaplonek, J. Kang, E. C. Lam, M. D. Burns, E. J. Farkas, J. Davis, B. Boribong, A. G. Edlow, A. Fasano, W. Shreffler, D. Zavadska, M. Johnson, D. Goldblatt, , A. Galit
This study compares humoral immune responses to mRNA vaccines in children aged 6-11 years, finding that a 100g dose elicits robust and dose-dependent cross-VOC antibody responses with preserved functional immunity.
bioRxiv · Oct 7, 2021 · PreprintImmunology